Lori Zarmer

Ms. Lori Zarmer

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RCRabail Arif Chaudhry
Rabail Arif Chaudhry
LZLori Zarmer
Lori Zarmer
KWKelly West
Kelly West
FCFrances Chung
Frances Chung
Obstructive sleep apnea (OSA), a common sleep disorder, poses significant challenges in perioperative management due to its complexity and multifactorial nature. With a global prevalence of approximately 22.6%, OSA often remains undiagnosed, and increases the risk of cardiac and respiratory postoperative complications. Preoperative screening has become essential in many institutions to identify patients at increased risk, and experts recommend proceeding with surgery in the absence of severe symptoms, albeit with heightened postoperative monitoring. Anesthetic and sedative agents exacerbate upper airway collapsibility and depress central respiratory activity, complicating intraoperative management, especially with neuromuscular blockade use. Additionally, OSA patients are particularly prone to opioid-induced respiratory depression, given their increased sensitivity to opioids and heightened pain perception. Thus, regional anesthesia and multimodal analgesia are strongly advocated to reduce perioperative complication risks. Postoperative care for OSA patients necessitates vigilant monitoring and tailored management strategies, such as supplemental oxygen and Positive Airway Pressure therapy, to minimize cardiorespiratory complications. Health care institutions are increasingly focusing on enhanced monitoring and resource allocation for patient safety. However, the rising prevalence of OSA, heterogeneity in disease severity, and lack of evidence for the efficacy of costly perioperative measures pose challenges. The development of effective screening and monitoring algorithms, alongside reliable risk predictors, is crucial for identifying OSA patients needing extended postoperative care. This review emphasizes a multidimensional approach in managing OSA patients throughout the perioperative period, aiming to optimize patient outcomes and minimize adverse outcomes.

Verified
Journal Article
Open access
PDF file
LZLori Zarmer
Lori Zarmer
MKMaaz Shah Khan
Maaz Shah Khan
GIGlenn Islat
Glenn Islat
HAHanan Alameddin
Hanan Alameddin
MMMaria A Massey
Maria A Massey
RCRabail Arif Chaudhry
Rabail Arif Chaudhry
Traumatic spinal cord injury (tSCI) is a devastating neurological disorder with profound effects on physical, psychological, and mental abilities. tSCI affects all age groups, with a higher incidence in elderly patients. There are many causes of tSCI, with motor vehicle accidents (MVA) and falls being the most common. The pathophysiology of tSCI is quite complex and involves primary and secondary injury. The primary injury directly results from the mechanical forces that caused the injury. Secondary injury is caused by long-term changes caused by inflammation, immune changes, and the formation of free radicals. Numerous studies have explored various medical and surgical treatment options that help mitigate long-term damage caused by tSCI and help improve quality of life. Currently, there are no treatments for tSCI that can reverse spinal cord damage or fully restore motor and sensory functions. However, many pharmacological and non-pharmacological options are being studied in tSCI patients. This review will discuss the background, pathophysiology, and clinical presentation of tSCI while also providing a detailed analysis of the recent advancements in treatment options.

10 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LZLori Zarmer
Lori Zarmer
MKMaaz Shah Khan
Maaz Shah Khan
GIGlenn Islat
Glenn Islat
HAHanan Alameddin
Hanan Alameddin
MMMaria A Massey
Maria A Massey
RCRabail Arif Chaudhry
Rabail Arif Chaudhry
Background/Objectives: Traumatic brain injury (TBI) is a major global cause of death and disability, with long-term cognitive, behavioral, and functional consequences. Despite its high burden, management is complicated by heterogeneous presentations and limited evidence. This review summarizes recent advances in monitoring, therapeutic strategies, neuroprotection, and rehabilitation, while highlighting future directions toward individualized and globalized care. Methods: This paper is a narrative review of clinical trials, systematic reviews, and observational studies, focusing on invasive and non-invasive monitoring, pharmacologic and non-pharmacologic interventions, neuroprotective agents, stem cell therapy, and advanced rehabilitation modalities. Results/Findings: Our review focuses on emerging monitoring techniques, including brain tissue oxygenation, cerebral microdialysis, and multimodal strategies, that provide detailed insights but lack standardized application. Interventions such as anti-inflammatory agents, hypothermia, hyperosmolar therapies, and metabolic suppression show mixed efficacy, with few therapies supported by high-level evidence. Novel agents like erythropoietin and progesterone demonstrate neuroprotective potential in preclinical models but remain inconclusive in clinical trials. Stem cell therapies and extracellular vesicle approaches are promising in early studies. Rehabilitation is expanding with virtual reality, robotics, and neurostimulation to promote neuroplasticity. Personalized medicine approaches incorporating biomarkers and machine learning may refine prognostication and guide therapy. Global inequities persist, particularly in low-resource settings. Conclusions: TBI care is shifting toward individualized, multimodal, and technology-driven strategies. While emerging therapies show promise, high-quality randomized trials and global implementation strategies are needed to improve outcomes and reduce disparities.